# \[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium\].

> PubMed lists PMID 14685711 in Zeitschrift fur Rheumatologie as Comparative Study, English Abstract, Journal Article, Review, with publication-date metadata of 2003-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-14685711-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-14685711-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-14685711-teriparatide-v1.json
- Content SHA-256: `534f3e584695e7eee240d15978f50b73e99d427dc1c69e3c070631c8796cdf20`

## Claims and source pins

### Headline

\[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium\]. ([`pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351`](#source-pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351))

### Summary

PubMed lists PMID 14685711 in Zeitschrift fur Rheumatologie as Comparative Study, English Abstract, Journal Article, Review, with publication-date metadata of 2003-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351`](#source-pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351))

### Paragraph 1

PubMed lists PMID 14685711 in Zeitschrift fur Rheumatologie as Comparative Study, English Abstract, Journal Article, Review, with publication-date metadata of 2003-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351`](#source-pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351`](#source-pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351))

## Sources

<a id="source-pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351"></a>
- **\[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium\]. · retained source version 1:2013-11-21:current:6b5a3f4263511ea8e8c12cf4b3d8915b4caa7d3f74530b049c33a02767238eeb** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/14685711/) (`pubmed-observation-pmid-14685711-2013-11-21-6b5a3f426351`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "\[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium\]." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-14685711-teriparatide-v1.json SHA-256: 534f3e584695e7eee240d15978f50b73e99d427dc1c69e3c070631c8796cdf20.